SMITA TUKARAM KUMBHAR; MANISH SUDESH BHATIA; SHITALKUMAR SHIVGONDA PATIL. Engineered atenolol-glycoconjugates to target H9c2 cardiomyocyte cell lines. ACTA INNOVATIONS, [S. l.], v. 43, p. 36–43, 2022. DOI: 10.62441/actainnovations.v43i.284. Disponível em: https://www.actainnovations.com/index.php/pub/article/view/43_3. Acesso em: 3 may. 2025.